share_log

Paycor HCM (NASDAQ:PYCR) PT Lowered to $29.00 at Deutsche Bank Aktiengesellschaft

Paycor HCM (NASDAQ:PYCR) PT Lowered to $29.00 at Deutsche Bank Aktiengesellschaft

佩高 HCM(納斯達克:PYCR)PT 在德意志銀行股票期間下調至 29.00 美元
kopsource ·  2023/01/26 03:22

Paycor HCM (NASDAQ:PYCR – Get Rating) had its price target reduced by Deutsche Bank Aktiengesellschaft from $36.00 to $29.00 in a report published on Monday, The Fly reports.

據The Fly報道,德意志銀行週一發佈的一份報告將Paycor HCM(納斯達克:PYCR-GET評級)的目標價從36.00美元下調至29.00美元。

PYCR has been the subject of a number of other reports. Moffett Nathanson initiated coverage on shares of Paycor HCM in a research report on Monday, January 9th. They issued a market perform rating and a $28.00 price objective for the company. The Goldman Sachs Group decreased their price target on shares of Paycor HCM from $34.00 to $30.00 and set a neutral rating for the company in a research report on Thursday, November 3rd. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of Hold and an average price target of $33.54.

PYCR一直是其他一些報告的主題。Moffett Nathanson在1月9日星期一的一份研究報告中發起了對Paycor HCM股票的報道。他們為該公司發佈了市場表現評級和28.00美元的目標價。高盛夫婦在11月3日星期四的一份研究報告中將Paycor HCM的目標價從34.00美元下調至30.00美元,並對該公司設定了中性評級。5名股票研究分析師對該股的評級為持有,3名分析師對該股的評級為買入。根據MarketBeat的數據,該股的平均評級為持有,平均目標價為33.54美元。

Get
到達
Paycor HCM
Paycor HCM
alerts:
警報:

Paycor HCM Trading Down 1.6 %

Paycor HCM降價1.6%

Shares of PYCR opened at $24.02 on Monday. The stock's fifty day simple moving average is $25.48 and its 200 day simple moving average is $27.77. Paycor HCM has a twelve month low of $20.14 and a twelve month high of $34.95. The firm has a market capitalization of $4.22 billion, a P/E ratio of -42.89 and a beta of 0.43.

週一,PYCR的股價開盤報24.02美元。該股的50日簡單移動均線為25.48美元,200日簡單移動均線為27.77美元。Paycor HCM的12個月低點為20.14美元,12個月高位為34.95美元。該公司的市值為42.2億美元,市盈率為-42.89,貝塔係數為0.43。

Paycor HCM (NASDAQ:PYCR – Get Rating) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. Paycor HCM had a negative return on equity of 0.78% and a negative net margin of 20.89%. The firm had revenue of $118.30 million during the quarter, compared to the consensus estimate of $113.37 million. Sell-side analysts predict that Paycor HCM will post -0.02 earnings per share for the current year.
納斯達克(Paycor HCM:PYCR-GET Rating)上一次公佈季度收益是在11月2日星期三。該公司公佈了該季度每股收益(EPS)(0.02美元),比普遍預期的(0.04美元)高出0.02美元。Paycor HCM的淨資產回報率為負0.78%,淨利潤率為負20.89%。該公司本季度營收為1.183億美元,而市場普遍預期為1.1337億美元。賣方分析師預測,Paycor HCM本年度的每股收益將為0.02美元。

Insider Buying and Selling

內幕買賣

In other news, major shareholder Pride Gp, Inc. sold 6,000,000 shares of Paycor HCM stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $28.45, for a total value of $170,700,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, major shareholder Pride Gp, Inc. sold 6,000,000 shares of the company's stock in a transaction on Thursday, December 1st. The stock was sold at an average price of $28.45, for a total transaction of $170,700,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jonathan Corr sold 1,508 shares of the firm's stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $23.68, for a total transaction of $35,709.44. Following the completion of the transaction, the director now owns 24,326 shares of the company's stock, valued at $576,039.68. The disclosure for this sale can be found here. 0.39% of the stock is owned by corporate insiders.

在其他新聞方面,大股東Pride GP,Inc.在12月1日星期四的一筆交易中出售了600萬股Paycor HCM股票。這些股票的平均價格為28.45美元,總價值為170,700,000.00美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可在以下網址獲得這個環節。在其他消息方面,大股東Pride GP,Inc.在12月1日星期四的一筆交易中出售了600萬股該公司股票。該股以28.45美元的平均價格出售,總成交金額為170,700,000.00美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過這個環節。此外,董事喬納森·科爾在一筆日期為1月5日(星期四)的交易中出售了1,508股該公司股票。該股以23.68美元的平均價格出售,總成交金額為35709.44美元。交易完成後,董事現在擁有24,326股該公司的股票,價值576,039.68美元。關於這次銷售的披露可以找到這裏。0.39%的股份由企業內部人士持有。

Institutional Trading of Paycor HCM

Paycor HCM的機構交易

Several hedge funds and other institutional investors have recently modified their holdings of the business. Clearbridge Investments LLC increased its stake in shares of Paycor HCM by 69.6% in the first quarter. Clearbridge Investments LLC now owns 4,506,633 shares of the company's stock worth $131,188,000 after acquiring an additional 1,849,370 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Paycor HCM by 32.4% in the second quarter. Price T Rowe Associates Inc. MD now owns 5,387,001 shares of the company's stock valued at $140,062,000 after purchasing an additional 1,316,954 shares in the last quarter. Vanguard Group Inc. increased its position in Paycor HCM by 26.3% in the 3rd quarter. Vanguard Group Inc. now owns 4,770,922 shares of the company's stock worth $141,029,000 after purchasing an additional 992,074 shares during the last quarter. Riverbridge Partners LLC purchased a new stake in shares of Paycor HCM during the 2nd quarter worth about $25,562,000. Finally, Victory Capital Management Inc. acquired a new stake in shares of Paycor HCM during the 3rd quarter valued at about $24,039,000. Institutional investors and hedge funds own 32.26% of the company's stock.

幾家對衝基金和其他機構投資者最近調整了對該公司的持股。ClearBridge Investments LLC在第一季度增持了Paycor HCM股票69.6%。ClearBridge Investments LLC在上個季度增持了1,849,370股後,現在擁有4,506,633股該公司股票,價值131,188,000美元。Price T Rowe Associates Inc.MD在第二季度增持了Paycor HCM 32.4%的股份。Price T Rowe Associates Inc.MD現在擁有5,387,001股該公司股票,價值140,062,000美元,上個季度又購買了1,316,954股。先鋒集團(Vanguard Group Inc.)在第三季度將其在Paycor HCM的頭寸增加了26.3%。先鋒集團目前持有該公司4,770,922股股票,價值141,029,000美元,上一季度又購買了992,074股。Riverbridge Partners LLC在第二季度購買了Paycor HCM的新股,價值約25,562,000美元。最後,勝利資本管理公司在第三季度收購了Paycor HCM的新股份,價值約24,039,000美元。機構投資者和對衝基金持有該公司32.26%的股票。

About Paycor HCM

關於Paycor HCM

(Get Rating)

(獲取評級)

Paycor HCM, Inc, through its subsidiaries, provides software-as-a-service (SaaS) human capital management (HCM) solutions for small and medium-sized businesses (SMBs) primarily in the United States. It offers cloud-native platform to address the comprehensive people management needs of SMB leaders. The company's SaaS based people management products include Cor HCM, a complete suite of HCM tools spanning HR, onboarding, payroll, compensation management, employee surveys, expenses, and reporting and analytics; Workforce Management, a solution with flexible time entry, overtime calculations, and scheduling capabilities with real-time payroll synchronization; Benefits Administration, a decision support solution to help leaders to streamline and optimize company's benefits administration; and Talent Management, an integrated compensation and performance management solution.

Paycor HCM,Inc.通過其子公司,主要為美國的中小型企業(SMB)提供軟件即服務(SaaS)人力資本管理(HCM)解決方案。它提供本地雲平臺,以滿足中小企業領導者的全面人員管理需求。該公司基於SaaS的人員管理產品包括COR HCM,這是一套完整的人性化管理工具,涵蓋人力資源、入職、薪資、薪酬管理、員工調查、費用以及報告和分析;勞動力管理,具有靈活的時間輸入、加班計算和計劃功能,並具有實時工資同步功能;福利管理,是幫助領導者簡化和優化公司福利管理的決策支持解決方案;人才管理,是集成的薪酬和績效管理解決方案。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Paycor HCM (PYCR)
  • AMD Is Still One Of The Best Semiconductor Stocks Out There
  • Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
  • Is The Bottom In For Cyber-Security Stocks?
  • Union Pacific, Norfolk Southern Pull into Buying Zone
  • Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
  • 免費獲取StockNews.com關於Paycor HCM的研究報告(PYCR)
  • AMD仍是市面上最好的半導體股票之一
  • 兩大股利大王:強生還是雅培?
  • 網絡安全類股已經見底了嗎?
  • 聯合太平洋,諾福克南方進入購買區
  • 柔順治療公司的差距增加了34%:未來還會有更多的好處嗎?

Receive News & Ratings for Paycor HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paycor HCM and related companies with MarketBeat.com's FREE daily email newsletter.

接受Paycor HCM日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Paycor HCM和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論